STT3A overexpression promoted tumor growth, increased TGF-β1 and IL-10 levels, and enhanced pulmonary metastasis, all of which were significantly reversed by DT treatment (Fig. 6H-M). The gene discussed is TGFB1; the disease is neoplasm.